$RDCM Balance Sheet | Understand Stock

$RDCM

$10.36 +$0.15 (1.47%) Close

$RDCM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q4 FY2015 As of Dec 31, 2015	Q4 FY2014 As of Dec 31, 2014	Q4 FY2013 As of Dec 31, 2013	Q4 FY2012 As of Dec 31, 2012	Q4 FY2011 As of Dec 31, 2011
CURRENT ASSETS:
Cash and cash equivalents
Restricted bank deposit
Short-term bank deposits
Trade receivables, net
Inventories, net
Other accounts receivable and prepaid expenses
Total current assets

NON- CURRENT ASSETS:
Long-term bank deposits
Severance pay fund
Other long-term receivables
Other long-term assets
Property and equipment, net
Operating lease right-of-use assets
Goodwill
Intangible assets, net

Total non-current assets
Total assets
CURRENT LIABILITIES:
Short-term bank credit, net
Short term loans
Trade payables
Employees and payroll accruals
Other accounts payable and accrued expenses
Deferred revenues and advances from customers
Deferred revenues
Current maturities of lease liabilities
Other liabilities and accrued expenses
Total current liabilities

NON-CURRENT LIABILITIES:
Deferred revenues
Accrued severance pay
Operating lease liabilities
Other liabilities and accrued expenses
Total non-current liabilities
Total liabilities

SHAREHOLDERS’ EQUITY:
Share capital:
Ordinary Shares of NIS 0.20 par value: Authorized: 20,000,000 shares at December 31, 2025 and 2024; 16,628,757 and 15,951,648 shares issued and 16,592,725 and 15,915,616 shares outstanding at December 31, 2025 and 2024, respectively
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total shareholders’ equity
Total liabilities and shareholders’ equity

Comments